Cargando…
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
Identification of targeted therapies for TNBC is an urgent medical need. Using a drug combination screen reliant on synthetic lethal interactions, we identified clinically relevant combination therapies for different TNBC subtypes. Two drug combinations targeting the BET family were further explored...
Autores principales: | Verma, Nandini, Vinik, Yaron, Saroha, Ashish, Nair, Nishanth Ulhas, Ruppin, Eytan, Mills, Gordon, Karn, Thomas, Dubey, Vinay, Khera, Lohit, Raj, Harsha, Maina, Flavio, Lev, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442484/ https://www.ncbi.nlm.nih.gov/pubmed/32937365 http://dx.doi.org/10.1126/sciadv.aba8968 |
Ejemplares similares
-
The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC
por: Khera, Lohit, et al.
Publicado: (2021) -
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
por: Kedan, Amir, et al.
Publicado: (2018) -
Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity
por: Cheng, Kuoyuan, et al.
Publicado: (2021) -
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators
por: Castellanet, Olivier, et al.
Publicado: (2021) -
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
por: Pal, Lipika R., et al.
Publicado: (2021)